Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Feb 8;18(4):1544-1548.
doi: 10.1016/j.radcr.2023.01.059. eCollection 2023 Apr.

A rare, giant, anaplastic oligodendroglioma

Pham Anh Tuan  1 , Nguyen Minh Duc  2
Affiliations
Case Reports

A rare, giant, anaplastic oligodendroglioma

Pham Anh Tuan et al. Radiol Case Rep. .

Abstract

Oligodendroglioma, the third most common glioma, accounts for 5% of primary brain tumors and around 20% of all glial neoplasms. They are quite uncommon in children. Here, we aimed to show an unusual case of a 9-year-old boy developing a huge anaplastic oligodendroglioma. A high-grade astrocytoma-like supratentorial tumor was discovered by a sophisticated brain scan employing magnetic resonance imaging. The tumor was identified by histopathology as an anaplastic oligodendroglioma. Anaplastic oligodendroglioma should be considered while making the differential diagnosis of high-grade astrocytoma notwithstanding its rarity.

Keywords: Anaplastic oligodendroglioma; Children; Giant; Magnetic resonance imaging.

PubMed Disclaimer

Figures

Fig 1
Fig. 1
(A) Axial T2-weighted and (B) FLAIR images show a heterogeneous mass located in the right parietal lobe.
Fig 2
Fig. 2
(A) Diffusion-weighted image and (B) Apparent diffusion coefficient map of tumor.
Fig 3
Fig. 3
Arterial spin-labeling image of the lesion.
Fig 4
Fig. 4
Diffusion tensor imaging of the tumor.
Fig 5
Fig. 5
Magnetic resonance spectroscopy of the lesion.
Fig 6
Fig. 6
Axial T1-weighted image with contrast agent of the tumor.
See this image and copyright information in PMC

References

    1. Ostrom QT, Gittleman H, Liao P, Vecchione-Koval T, Wolinsky Y, Kruchko C, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014. Neuro Oncol. 2017;19(Suppl. 5):v1–v88. - PMC - PubMed
    1. Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131(6):803–820. - PubMed
    1. Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;23(8):1231–1251. - PMC - PubMed
    1. Anderson MD, Gilbert MR. Treatment recommendations for anaplastic oligodendrogliomas that are codeleted. Oncology (Williston Park) 2013;27(4) 315-20, 322. - PubMed
    1. Johnson DR, Diehn FE, Giannini C, Jenkins RB, Jenkins SM, Parney IF, et al. Genetically defined oligodendroglioma is characterized by indistinct tumor borders at MRI. AJNR Am J Neuroradiol. 2017;38(4):678–684. - PMC - PubMed

Publication types

LinkOut - more resources